rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2008-3-3
|
pubmed:abstractText |
Unknown primary head and neck cancers often require comprehensive mucosal and bilateral neck irradiation. With conventional techniques, significant toxicity can develop. Intensity-modulated radiotherapy (IMRT) has the potential to minimize the toxicity.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0360-3016
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1100-7
|
pubmed:meshHeading |
pubmed-meshheading:17980501-Adult,
pubmed-meshheading:17980501-Aged,
pubmed-meshheading:17980501-Aged, 80 and over,
pubmed-meshheading:17980501-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17980501-Carboplatin,
pubmed-meshheading:17980501-Carcinoma, Squamous Cell,
pubmed-meshheading:17980501-Cisplatin,
pubmed-meshheading:17980501-Combined Modality Therapy,
pubmed-meshheading:17980501-Disease-Free Survival,
pubmed-meshheading:17980501-Female,
pubmed-meshheading:17980501-Fluorouracil,
pubmed-meshheading:17980501-Head and Neck Neoplasms,
pubmed-meshheading:17980501-Humans,
pubmed-meshheading:17980501-Male,
pubmed-meshheading:17980501-Middle Aged,
pubmed-meshheading:17980501-Neoplasms, Unknown Primary,
pubmed-meshheading:17980501-Radiation Injuries,
pubmed-meshheading:17980501-Radiotherapy, Intensity-Modulated,
pubmed-meshheading:17980501-Radiotherapy Dosage
|
pubmed:year |
2008
|
pubmed:articleTitle |
Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
|
pubmed:affiliation |
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10022, USA. mlklem@yahoo.com
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|